SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-039726
Filing Date
2024-09-06
Accepted
2024-09-06 17:02:29
Documents
13
Period of Report
2024-09-01
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K til-20240901.htm   iXBRL 8-K 31545
  Complete submission text file 0001628280-24-039726.txt   158833

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20240901.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20240901_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20240901_pre.xml EX-101.PRE 13038
15 EXTRACTED XBRL INSTANCE DOCUMENT til-20240901_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 241285137
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)